Rhinomed Limited announced consolidated earnings results for the six months ended December 31, 2016. For the period, the company reported Revenue from continuing operations was AUD 1,214,453 against revenue from continuing operations of AUD 522,165 a year ago. Loss before income tax for the period was AUD 1,631,020 against loss before income tax for the period of AUD 3,214,479 a year ago. Net loss for the period was AUD 1,352,020 against net loss for the period of AUD 2,777,184 a year ago. Net loss attributable to owners of the parent entity was AUD 1,353,352 against net loss attributable to owners of the parent entity of AUD 2,784,085 a year ago. Basic and diluted loss per share was 0.17 cents against basic and diluted loss per share of 0.48 cents a year ago. Net cash flows used in operating activities was AUD 1,817,515 against net cash flows used in operating activities of AUD 2,836,906 a year ago.